Havrdova, E., Horakova, D., & Kovarova, I. (2015). Alemtuzumab in the treatment of multiple sclerosis: Key clinical trial results and considerations for use. Ther Adv Neurol Disord.
Citación estilo ChicagoHavrdova, Eva, Dana Horakova, and Ivana Kovarova. "Alemtuzumab in the Treatment of Multiple Sclerosis: Key Clinical Trial Results and Considerations for Use." Ther Adv Neurol Disord 2015.
Cita MLAHavrdova, Eva, Dana Horakova, and Ivana Kovarova. "Alemtuzumab in the Treatment of Multiple Sclerosis: Key Clinical Trial Results and Considerations for Use." Ther Adv Neurol Disord 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.